Related Experiment Videos

Granisetron reduces vomiting after strabismus surgery and tonsillectomy in children

Y Fujii1, H Tanaka, H Toyooka

  • 1Department of Anaesthesiology and Critical Care Medicine, Tokyo Medical and Dental University School of Medicine, Japan.

Insights

Granisetron effectively prevents postoperative vomiting and retching in children undergoing strabismus repair and tonsillectomy. This antiemetic significantly reduced nausea symptoms compared to placebo, improving patient recovery.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Surgical Outcomes

Background:

  • Postoperative nausea and vomiting (PONV) are common complications in pediatric surgery.
  • Selective 5-hydroxytryptamine type 3 receptor antagonists offer a targeted approach to managing PONV.

Purpose of the Study:

  • To assess the antiemetic effectiveness of granisetron in pediatric patients.
  • To evaluate granisetron's impact on postoperative vomiting and retching following strabismus repair and tonsillectomy.

Main Methods:

  • A randomized, placebo-controlled, double-blind study involving 50 pediatric patients (4-10 years).
  • Patients received either granisetron (40 mcg/kg) or placebo intravenously post-anesthesia induction.
  • Postoperative retching and vomiting frequencies were recorded over 24 hours.

Main Results:

  • Granisetron significantly reduced the incidence of retching (12% vs. 36%) and vomiting (8% vs. 32%) compared to placebo (P < 0.05).
  • No patients receiving granisetron required rescue antiemetic medication, unlike four in the placebo group.

Conclusions:

  • Granisetron demonstrates significant efficacy in preventing postoperative retching and vomiting in pediatric patients.
  • The study supports granisetron as a valuable antiemetic for children undergoing specific surgical procedures.
Abstract

Related Concept Videos